CD6 and myeloid sarcoma: When they specifically analyzed proteins of MS susceptibility genes, eight (LCK, GRAP2, CD5, ZC3HAV1, SAE1, EPPK1 and CD6 in CD4+ T cells and TNFAIP8 in CD8+T cells) were found to be dysregulated in the T cells of MS patients [151].